NCT01361282

Brief Summary

Many patients with endothelial dysfunction also present with cataracts. It is therefore common practice to perform cataract extraction and intraocular lens (IOL) implantation during the same operation and immediately prior to Descemet's Stripping Automated Endothelial Keratoplasty (DSAEK), in order to minimize trips to the operating room and the associated risks of ocular surgery. However, the unique posterior corneal anatomy of the DSAEK recipient makes it difficult to predict pre-operatively the proper power of IOL to place, and some patients end up with a mismatched lens that requires spectacle correction. The current gold standard for IOL power calculation (A-Scan optical biometry) takes measurements of the anterior surface of the cornea and makes assumptions about the posterior surface that are violated by the unique hourglass shape of the donor DSAEK graft. New optical coherence tomography (OCT) technology provides us with the ability to measure curvature in both the anterior and posterior aspects of the cornea in order to generate an IOL calculation that has the potential to give more accurate results for our DSAEK patients. The investigators will be using the Optovue to perform corneal power analysis on patients who have already received DSAEK and cataract surgery, in order to compare the post-op Optovue power calculations to the pre-operative power calculations provided by the A-Scan. If the OCT is shown to provide accurate IOL power calculations, then some patients might be better served by a two-stage procedure where DSAEK is performed and then followed six months later by cataract surgery using the OCT to calculate IOL power.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Nov 2010

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 9, 2010

Completed
7 months until next milestone

First Submitted

Initial submission to the registry

May 25, 2011

Completed
1 day until next milestone

First Posted

Study publicly available on registry

May 26, 2011

Completed
5.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 9, 2016

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 9, 2016

Completed
Last Updated

March 13, 2017

Status Verified

March 1, 2017

Enrollment Period

5.8 years

First QC Date

May 25, 2011

Last Update Submit

March 8, 2017

Conditions

Keywords

Total Corneal PowerOptical Coherence TomographyDescemet Stripping Endothelial Keratoplasty

Study Arms (1)

Triple Procedure

All qualifying patients will have received DSAEK with concurrent cataract extraction and intraocular lens placement. Data collection will occur between 6-18 months post-operation.

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

All study subjects will have received Descemet's Stripping Automated Endothelial Keratoplasty (DSAEK) for Fuchs' Endothelial Dystrophy, together with concurrent cataract surgery. Data collection will occur between 6 and 18 months following surgery.

You may qualify if:

  • year of age or older
  • Diagnosis of Fuchs' Endothelial Dystrophy with cataract
  • Recent history of DSAEK with concurrent phacoemulsification \& intraocular lens (IOL) implantation

You may not qualify if:

  • Diagnosis of ocular comorbidity that might be limiting to visual acuity (glaucoma, retinal disease, surface irregularities, etc.)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Devers Eye Institute

Portland, Oregon, 97210, United States

Location

MeSH Terms

Conditions

Fuchs' Endothelial DystrophyCataract

Condition Hierarchy (Ancestors)

Corneal Dystrophies, HereditaryCorneal DiseasesEye DiseasesEye Diseases, HereditaryGenetic Diseases, InbornCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesLens Diseases

Study Officials

  • Mark A Terry, MD

    Devers Eye Institute

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Director of Corneal Services

Study Record Dates

First Submitted

May 25, 2011

First Posted

May 26, 2011

Study Start

November 9, 2010

Primary Completion

September 9, 2016

Study Completion

September 9, 2016

Last Updated

March 13, 2017

Record last verified: 2017-03

Locations